PBLS
Parabilis Medicines, Inc. - Common Stock (PBLS)
$35
About Parabilis Medicines, Inc. - Common Stock (PBLS)
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Details
Daily high
$39.81
Daily low
$35.60
Price at open
$37.18
52 Week High
$39.81
52 Week Low
$20.00
Market cap
4.4B
Dividend yield
-
Volume
639,143
Avg. volume
348,446
P/E ratio
--
Parabilis Medicines, Inc. - Common Stock News
Details
Daily high
$39.81
Daily low
$35.60
Price at open
$37.18
52 Week High
$39.81
52 Week Low
$20.00
Market cap
4.4B
Dividend yield
-
Volume
639,143
Avg. volume
348,446
P/E ratio
--